FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2495073521> ?p ?o ?g. }

• W2495073521 endingPage "54273" @default.
• W2495073521 startingPage "54263" @default.
• W2495073521 abstract "// Guo-Kun Wang 1,* , Song-Hua Li 2,* , Zhi-Min Zhao 1 , Su-Xuan Liu 2 , Guan-Xin Zhang 1 , Fan Yang 1 , Yang Wang 1 , Feng Wu 3 , Xian-Xian Zhao 2 and Zhi-Yun Xu 1 1 Institution of Cardiac Surgery, Department of Cardiovascular Surgery, Changhai Hospital, Second Military Medical University, Shanghai, China 2 Department of Cardiology, Changhai Hospital, Second Military Medical University, Shanghai, China 3 Department of Cardiology, 98th Military Hospital, Huzhou, Zhejiang, China * These authors have contributed equally to this work Correspondence to: Zhi-yun Xu, email: // Xian-Xian Zhao, email: // Keywords : pulmonary arterial hypertension, heat shock protein 90, pulmonary artery smooth muscle cells, pulmonary arteriole remodeling, Pathology Section Received : November 13, 2015 Accepted : July 17, 2016 Published : July 26, 2016 Abstract While the molecular chaperone heat shock protein 90 (HSP90) is involved in a multitude of physiological and pathological processes, its role relating to pulmonary arterial hypertension (PAH) remains unclear. In the present study, we investigated the effect in which HSP90 improves pulmonary arteriole remodeling, and explored the therapeutic utility of targeting HSP90 as therapeutic drug for PAH. By Elisa and immunohistochemistry, HSP90 was found to be increased in both plasma and membrane walls of pulmonary arterioles from PAH patients. Moreover, plasma HSP90 levels positively correlated with mean pulmonary arterial pressure and C-reactive protein. In a monocrotaline-induced rat model of PH, we found that 17-AAG, a HSP90-inhibitor, alleviated the progress of PH, demonstrated by lower pulmonary arterial pressure and absence of right ventricular hypertrophy. Immunohistochemical staining demonstrated that 17-AAG improved pulmonary arteriole remodeling on the basis of reduced wall thickness and wall area. The inflammatory response attributed to PH could be attenuated by 17-AAG through reduction of NF-κB signaling. Moreover, 17-AAG was found to suppress PDGF-stimulated proliferation and migration of pulmonary artery smooth muscle cells (PASMCs) through induction of cell cycle arrest in the G1 phase. In conclusion, HSP90 inhibitor 17-AAG could improve pulmonary arteriole remodeling via inhibiting the excessive proliferation of PASMCs, and inhibition of HSP90 may represent a therapeutic avenue for the treatment of PAH." @default.
• W2495073521 created "2016-08-23" @default.
• W2495073521 creator A5010126264 @default.
• W2495073521 creator A5022595896 @default.
• W2495073521 creator A5025133496 @default.
• W2495073521 creator A5025453964 @default.
• W2495073521 creator A5032035426 @default.
• W2495073521 creator A5036337647 @default.
• W2495073521 creator A5036338427 @default.
• W2495073521 creator A5065521109 @default.
• W2495073521 creator A5082956701 @default.
• W2495073521 creator A5087034276 @default.
• W2495073521 date "2016-07-26" @default.
• W2495073521 modified "2023-09-25" @default.
• W2495073521 title "Inhibition of heat shock protein 90 improves pulmonary arteriole remodeling in pulmonary arterial hypertension" @default.
• W2495073521 cites W1966006405 @default.
• W2495073521 cites W1989480741 @default.
• W2495073521 cites W1993973661 @default.
• W2495073521 cites W2002280519 @default.
• W2495073521 cites W2046702878 @default.
• W2495073521 cites W2063956958 @default.
• W2495073521 cites W2066163949 @default.
• W2495073521 cites W2099548121 @default.
• W2495073521 cites W2100288953 @default.
• W2495073521 cites W2100611890 @default.
• W2495073521 cites W2103284264 @default.
• W2495073521 cites W2115527176 @default.
• W2495073521 cites W2123476312 @default.
• W2495073521 cites W2143199174 @default.
• W2495073521 cites W2143657744 @default.
• W2495073521 cites W2157261840 @default.
• W2495073521 cites W2165812090 @default.
• W2495073521 cites W2181762443 @default.
• W2495073521 cites W2183644045 @default.
• W2495073521 cites W2582602949 @default.
• W2495073521 doi "https://doi.org/10.18632/oncotarget.10855" @default.
• W2495073521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5342340" @default.
• W2495073521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27472464" @default.
• W2495073521 hasPublicationYear "2016" @default.
• W2495073521 type Work @default.
• W2495073521 sameAs 2495073521 @default.
• W2495073521 citedByCount "28" @default.
• W2495073521 countsByYear W24950735212017 @default.
• W2495073521 countsByYear W24950735212018 @default.
• W2495073521 countsByYear W24950735212019 @default.
• W2495073521 countsByYear W24950735212020 @default.
• W2495073521 countsByYear W24950735212021 @default.
• W2495073521 countsByYear W24950735212022 @default.
• W2495073521 countsByYear W24950735212023 @default.
• W2495073521 crossrefType "journal-article" @default.
• W2495073521 hasAuthorship W2495073521A5010126264 @default.
• W2495073521 hasAuthorship W2495073521A5022595896 @default.
• W2495073521 hasAuthorship W2495073521A5025133496 @default.
• W2495073521 hasAuthorship W2495073521A5025453964 @default.
• W2495073521 hasAuthorship W2495073521A5032035426 @default.
• W2495073521 hasAuthorship W2495073521A5036337647 @default.
• W2495073521 hasAuthorship W2495073521A5036338427 @default.
• W2495073521 hasAuthorship W2495073521A5065521109 @default.
• W2495073521 hasAuthorship W2495073521A5082956701 @default.
• W2495073521 hasAuthorship W2495073521A5087034276 @default.
• W2495073521 hasBestOaLocation W24950735211 @default.
• W2495073521 hasConcept C104317684 @default.
• W2495073521 hasConcept C126322002 @default.
• W2495073521 hasConcept C142724271 @default.
• W2495073521 hasConcept C164705383 @default.
• W2495073521 hasConcept C185592680 @default.
• W2495073521 hasConcept C205260736 @default.
• W2495073521 hasConcept C2775932338 @default.
• W2495073521 hasConcept C2777560012 @default.
• W2495073521 hasConcept C2779482390 @default.
• W2495073521 hasConcept C2780930700 @default.
• W2495073521 hasConcept C2780940725 @default.
• W2495073521 hasConcept C55493867 @default.
• W2495073521 hasConcept C71924100 @default.
• W2495073521 hasConcept C72859922 @default.
• W2495073521 hasConceptScore W2495073521C104317684 @default.
• W2495073521 hasConceptScore W2495073521C126322002 @default.
• W2495073521 hasConceptScore W2495073521C142724271 @default.
• W2495073521 hasConceptScore W2495073521C164705383 @default.
• W2495073521 hasConceptScore W2495073521C185592680 @default.
• W2495073521 hasConceptScore W2495073521C205260736 @default.
• W2495073521 hasConceptScore W2495073521C2775932338 @default.
• W2495073521 hasConceptScore W2495073521C2777560012 @default.
• W2495073521 hasConceptScore W2495073521C2779482390 @default.
• W2495073521 hasConceptScore W2495073521C2780930700 @default.
• W2495073521 hasConceptScore W2495073521C2780940725 @default.
• W2495073521 hasConceptScore W2495073521C55493867 @default.
• W2495073521 hasConceptScore W2495073521C71924100 @default.
• W2495073521 hasConceptScore W2495073521C72859922 @default.
• W2495073521 hasIssue "34" @default.
• W2495073521 hasLocation W24950735211 @default.
• W2495073521 hasLocation W24950735212 @default.
• W2495073521 hasLocation W24950735213 @default.
• W2495073521 hasLocation W24950735214 @default.
• W2495073521 hasOpenAccess W2495073521 @default.
• W2495073521 hasPrimaryLocation W24950735211 @default.
• W2495073521 hasRelatedWork W1983508961 @default.
• W2495073521 hasRelatedWork W2014889446 @default.

• next